Search research articles
Contact Us
Filters
Showing results (41-50 of 199) with videos related to
Page
of 20
Sort By:
The Journal of Biological Chemistry
|
August 5, 1988
Molecular defect in factor IXBm Lake Elsinore. Substitution of Ala390 by Val in the catalytic domain
S G Spitzer, U R Pendurthi, C K Kasper, et al.
Journal of Pharmacological and Toxicological Methods
|
December 1, 1996
Quantification of rate-dependent effects of verapamil, diltiazem, and digoxin on atrioventricular conduction
I Schwarzl, U Stark, K Kasper, et al.
American Journal of Hematology
|
July 1, 1993
Comparison of the behavior of normal factor IX and the factor IX Bm variant Hilo in the prothrombin time test using tissue factors from bovine, human, and rabbit sources
J B Lefkowitz, D M Monroe, C K Kasper, et al.
Klinische Monatsblatter Fur Augenheilkunde
|
March 21, 2008
[Epitheliotrophic capacity of serum eye drops from healthy donors versus serum from immunosuppressed patients with rheumatoid arthritis]
S Harloff, D Hartwig, K Kasper, et al.
The Journal of Clinical Investigation
|
January 1, 1985
Characterization of three abnormal factor IX variants (Bm Lake Elsinore, Long Beach, and Los Angeles) of hemophilia-B. Evidence for defects affecting the latent catalytic site
P Usharani, B J Warn-Cramer, C K Kasper, et al.
Vaccine
|
July 28, 2018
Infectious diseases consult improves vaccination adherence in kidney transplant candidates
A K Kasper, A M Pallotta, C S Kovacs, et al.
Clinical Cardiology
|
December 1, 1993
A comparison of the effects of adenosine and verapamil on the conduction and pacemaker system of isolated guinea pig hearts
G Stark, U Stark, M Bachernegg, et al.
Thrombosis and Haemostasis
|
February 23, 1981
Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factor
B Osterud, C K Kasper, K K Lavine, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|
July 10, 2008
[On the use of autologous serum eyedrops in Germany : results of a survey among members of the Cornea Section of the German Ophthalmological Society (DOG)]
K Kasper, L Godenschweger, D Hartwig, et al.
Blood
|
February 15, 1989
Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype)
P H Reitsma, T Mandalaki, C K Kasper, et al.
Page
of 20
Search research articles
Search
Showing results (41-50 of 199) with videos related to
Sort By:
Page
of 20
The Journal of Biological Chemistry
|
August 5, 1988
Molecular defect in factor IXBm Lake Elsinore. Substitution of Ala390 by Val in the catalytic domain
S G Spitzer, U R Pendurthi, C K Kasper, et al.
Journal of Pharmacological and Toxicological Methods
|
December 1, 1996
Quantification of rate-dependent effects of verapamil, diltiazem, and digoxin on atrioventricular conduction
I Schwarzl, U Stark, K Kasper, et al.
American Journal of Hematology
|
July 1, 1993
Comparison of the behavior of normal factor IX and the factor IX Bm variant Hilo in the prothrombin time test using tissue factors from bovine, human, and rabbit sources
J B Lefkowitz, D M Monroe, C K Kasper, et al.
Klinische Monatsblatter Fur Augenheilkunde
|
March 21, 2008
[Epitheliotrophic capacity of serum eye drops from healthy donors versus serum from immunosuppressed patients with rheumatoid arthritis]
S Harloff, D Hartwig, K Kasper, et al.
The Journal of Clinical Investigation
|
January 1, 1985
Characterization of three abnormal factor IX variants (Bm Lake Elsinore, Long Beach, and Los Angeles) of hemophilia-B. Evidence for defects affecting the latent catalytic site
P Usharani, B J Warn-Cramer, C K Kasper, et al.
Vaccine
|
July 28, 2018
Infectious diseases consult improves vaccination adherence in kidney transplant candidates
A K Kasper, A M Pallotta, C S Kovacs, et al.
Clinical Cardiology
|
December 1, 1993
A comparison of the effects of adenosine and verapamil on the conduction and pacemaker system of isolated guinea pig hearts
G Stark, U Stark, M Bachernegg, et al.
Thrombosis and Haemostasis
|
February 23, 1981
Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factor
B Osterud, C K Kasper, K K Lavine, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|
July 10, 2008
[On the use of autologous serum eyedrops in Germany : results of a survey among members of the Cornea Section of the German Ophthalmological Society (DOG)]
K Kasper, L Godenschweger, D Hartwig, et al.
Blood
|
February 15, 1989
Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype)
P H Reitsma, T Mandalaki, C K Kasper, et al.
Page
of 20